Deitelzweig, S. ., Luo, X. ., Gupta, K. ., Trocio, J. ., Mardekian, J. ., Curtice, T. ., … Lin, J. . (2018). All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care Costs Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Oral Anticoagulants. Clinical and Applied Thrombosis Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis Hemostasis, 1076029617750269. https://doi.org/10.1177/1076029617750269 (Original work published 2018)

Li, X. ., Keshishian, A. ., Hamilton, M. ., Horblyuk, R. ., Gupta, K. ., Luo, X. ., … Deitelzweig, S. . Apixaban 5 and 2.5 mg twice-daily versus warfarin for stroke prevention in nonvalvular atrial fibrillation patients: Comparative effectiveness and safety evaluated using a propensity-score-matched approach. PloS One, 13(1), e0191722. https://doi.org/10.1371/journal.pone.0191722 (Original work published 2018)

Tepper, P. ., Liu, X. ., Hamilton, M. ., Mardekian, J. ., Petkun, W. ., Tan, W. ., & Singer, D. . (2017). Ischemic Stroke in Nonvalvular Atrial Fibrillation at Warfarin Initiation: Assessment via a Large Insurance Database. Stroke, 48(6), 1487-1494. https://doi.org/10.1161/STROKEAHA.116.015535